Home › Funds › Sarissa Capital Management LP › BIIB
Sarissa Capital Management LP position in BIIB
BIOGEN INC · Health Care
Sarissa Capital Management LP reported holding 950 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$205K, representing 0.12% of its reported portfolio and ranking #10 among its reported holdings. Sarissa Capital Management LP has disclosed BIIB holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sarissa Capital Management LP's BIIB position evolved
Sarissa Capital Management LP first disclosed a stake in BIIB in Q3 2023 at 643,000 shares (US$165.3M). The position peaked in Q4 2023 at 643,000 shares, worth US$166.4M. Across 6 filings, Sarissa Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 950 shares valued at US$205K. Notable position changes include a 96% trim in Q3 2024 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 643.00K | $165.26M | New |
| Q4 2023 | 643.00K | $166.39M | Hold |
| Q1 2024 | 643.00K | $138.65M | Hold |
| Q2 2024 | 643.00K | $149.06M | Hold |
| Q3 2024 | 26.95K | $5.22M | Reduce |
| Q2 2026 | 950 | $205.26K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Sarissa Capital Management LP
FAQ
How long has Sarissa Capital Management LP held BIIB?
Sarissa Capital Management LP has disclosed BIIB holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is Sarissa Capital Management LP's current position in BIIB?
As of Q2 2026, Sarissa Capital Management LP holds 950 shares of BIIB (BIOGEN INC), valued at $205.26K, representing 0.12% of its reported portfolio and ranking #10.
Has Sarissa Capital Management LP been buying or selling BIIB?
In the latest 13F filing (Q2 2026), Sarissa Capital Management LP newly opened its position in BIIB. The position peaked in Q4 2023 at 643.00K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.